Company performance
Add to research
Current Price
as of Apr 17, 2025$2.47
P/E Ratio
N/A
Market Cap
$2.18B
Description
Add to research
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerIBRX
- Price$2.47-0.40%
Trading Information
- Market cap$2.18B
- Float10.40%
- Average Daily Volume (1m)7,823,071
- Average Daily Volume (3m)6,456,637
- EPS-$0.59
Company
- Revenue$14.75M
- Rev growth (1yr)2,270.58%
- Net income-$413.56M
- Gross margin-19.05%
- EBITDA margin-2,215.18%
- EBITDA-$326.63M
- EV$2.43B
- EV/Revenue165.08
- P/EN/A
- P/S117.33
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account
Wikipedia